Didem, A. Y. Et Al. 2012. Side effects and clinical course of omalizumab in patients with severe persistent asthma. 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Geneva, Switzerland), 452-453.

Didem, A. Y., Erbay, R., Polat, H., & GÜMÜŞLÜ, S., (2012). Side effects and clinical course of omalizumab in patients with severe persistent asthma . 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.452-453). Geneva, Switzerland

Didem, Arzu Et Al. "Side effects and clinical course of omalizumab in patients with severe persistent asthma," 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Geneva, Switzerland, 2012

Didem, Arzu Y. Et Al. "Side effects and clinical course of omalizumab in patients with severe persistent asthma." 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Geneva, Switzerland, pp.452-453, 2012

Didem, A. Y. Et Al. (2012) . "Side effects and clinical course of omalizumab in patients with severe persistent asthma." 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Geneva, Switzerland, pp.452-453.

@conferencepaper{conferencepaper, author={Arzu Y. Didem Et Al. }, title={Side effects and clinical course of omalizumab in patients with severe persistent asthma}, congress name={31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Geneva}, country={Switzerland}, year={2012}, pages={452-453} }